B-cell prolymphocytic leukemia overview: Difference between revisions
Carlos Lopez (talk | contribs) No edit summary |
Carlos Lopez (talk | contribs) No edit summary |
||
| Line 16: | Line 16: | ||
==[[B-cell prolymphocytic leukemia pathophysiology|Pathophysiology]]== | ==[[B-cell prolymphocytic leukemia pathophysiology|Pathophysiology]]== | ||
B-cell prolymphocytic leukemia arises from mature B-cells, which are hematologic white cells that are normally involved in the in the [[humoral immunity]] component of the adaptive immune system by secreting [[antibodies]]. | |||
==[[B-cell prolymphocytic leukemia differential diagnosis|Differentiating B-cell prolymphocytic leukemia from other Diseases]]== | ==[[B-cell prolymphocytic leukemia differential diagnosis|Differentiating B-cell prolymphocytic leukemia from other Diseases]]== | ||
B-cell prolymphocytic leukemia must be differentiated from other diseases such as [[T-cell prolymphocytic leukemia]], [[chronic lymphocytic leukemia]] and [[hairy cell leukemia]]. | |||
==[[B-cell prolymphocytic leukemia epidemiology and demographics|Epidemiology and Demographics]]== | ==[[B-cell prolymphocytic leukemia epidemiology and demographics|Epidemiology and Demographics]]== | ||
The incidence of B-cell prolymphocytic leukemia is 1% of lymphocytic leukemias. B-cell prolymphocytic leukemia affects men and women equally. | |||
==[[B-cell prolymphocytic leukemia risk factors|Risk Factors]]== | ==[[B-cell prolymphocytic leukemia risk factors|Risk Factors]]== | ||
| Line 26: | Line 29: | ||
==[[B-cell prolymphocytic leukemia natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ==[[B-cell prolymphocytic leukemia natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ||
The prognosis for B-cell prolymphocytic leukemia is generally poor. | |||
==Diagnosis== | ==Diagnosis== | ||
Revision as of 14:29, 7 October 2015
|
B-cell prolymphocytic leukemia |
|
Differentiating B-cell prolymphocytic leukemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
B-cell prolymphocytic leukemia overview On the Web |
|
American Roentgen Ray Society Images of B-cell prolymphocytic leukemia overview |
|
Directions to Hospitals Treating B-cell prolymphocytic leukemia |
|
Risk calculators and risk factors for B-cell prolymphocytic leukemia overview |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Carlos A Lopez, M.D. [2]
Synonyms and keywords: B-PLL, Prolymphocytic leukemia, B-cell type
Overview
B-cell prolymphocytic leukemia is a form of leukemia or cancer of the white blood cells
Historical Perspective
Classification
Pathophysiology
B-cell prolymphocytic leukemia arises from mature B-cells, which are hematologic white cells that are normally involved in the in the humoral immunity component of the adaptive immune system by secreting antibodies.
Differentiating B-cell prolymphocytic leukemia from other Diseases
B-cell prolymphocytic leukemia must be differentiated from other diseases such as T-cell prolymphocytic leukemia, chronic lymphocytic leukemia and hairy cell leukemia.
Epidemiology and Demographics
The incidence of B-cell prolymphocytic leukemia is 1% of lymphocytic leukemias. B-cell prolymphocytic leukemia affects men and women equally.
Risk Factors
Screening
Natural History, Complications and Prognosis
The prognosis for B-cell prolymphocytic leukemia is generally poor.
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | CT | MRI | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies